J Clin Oncol 23 (33): 8322-30, 2005.[PUBMED Abstract] Misset JL, Dieras V, Gruia G, et al.: Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer.
Ann Oncol 10 (5): 553-60, 1999.[PUBMED Abstract] Buzdar AU, Kau SW, Smith TL, et al.: Ten-year results of FAC adjuvant chemotherapy trial in breast cancer.
Am J Clin Oncol 12 (2): 123-8, 1989.[PUBMED Abstract] Tormey DC, Gelman R, Band PR, et al.: Comparison of induction chemotherapies for metastatic breast cancer.
An Eastern Cooperative Oncology Group Trial.
Cancer 50 (7): 1235-44, 1982.[PUBMED Abstract] Jassem J, Pieńkowski T, Płuzańska A, et al.: Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.